FDA Law Blog

JANUARY 7, 2024

A review of FDA’s Postmarketing Requirements and Commitments database reveals that one of the most common reasons FDA requires postmarketing studies is to assess the impact of a drug on maternal and fetal outcomes when taken by pregnant women. For many drugs, both a registry and an outcomes study are required.

Marketing 59

Marketing Drugs Regulation Cosmetics 59

Pharmaceutical Technology

MARCH 30, 2023

The FDA’s proposed FY2024 Budget tops $7bn, to be shared between drug, food, and cosmetics tasks and overheads such as buildings; this is $372m higher than in FY 2023, a 10% increase. Recall powers for all drugs: The budget reveals legislative as well as spending plans; the agency wants to expand its authority to recall any drug.

Contract Manufacturing 147

Contract Manufacturing Manufacturing Pharma Companies Cosmetics 147

Delveinsight

SEPTEMBER 20, 2021

The condition is not life-threatening, however, is often wrongly presumed as purely a cosmetic problem leading to ignorance and delay in the treatment. The Onychomycosis treatment market offers several options, including oral antifungals, topical antifungals, and devices. Penlac (Valeant Pharmaceuticals, Inc.),

Marketing 74

Marketing Cosmetics Drug Delivery Clinical Development 74

FDA Law Blog

JULY 7, 2022

Livornese — Ten years in the making, a proposed rule was issued by FDA last week that has the potential to bring some prescription drugs that have not been able to gain an OTC approval to retail shelves at long last. To date, no OTC drug has been approved under this guidance.

Drugs 52

Drugs Marketing Containment Production 52

Pharmaceutical Technology

MARCH 1, 2023

According to GlobalData, Phase I drugs for Neuroendocrine Tumors have a 74% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how Nedisertib’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks.

Gene Editing 100

Gene Editing DNA Cosmetics Life Science 100

Pharmaceutical Technology

MARCH 1, 2023

According to GlobalData, Phase I drugs for Head And Neck Cancer Squamous Cell Carcinoma have an 80% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how Nedisertib’s drug-specific PTSR and Likelihood of Approval (LoA) scores compare to the indication benchmarks.

Gene Editing 100

Gene Editing DNA Cosmetics Life Science 100

Pharma in Brief

NOVEMBER 20, 2023

The Courts’ decisions provide insight into how natural health products are distinguished, under federal law, from cosmetics and from drugs subject to the Food and Drug Regulations. These distinctions are important as they determine the regulatory burden required to market a product in Canada.

Production 52

Production Cosmetics Regulation Branding 52

XTalks

JANUARY 25, 2023

Massachusetts-based TheracosBio has received US Food and Drug Administration (FDA) approval for diabetes med Brenzavvy (bexagliflozin) to help improve glycemic control in adults with type 2 diabetes. The drug is taken once a day in conjunction with diet and exercise. What is the Animal Drug Regulatory Process?

FDA Approval 52

FDA Approval Drugs Life Science Cosmetics 52

FDA Law Blog

JANUARY 4, 2024

This unique forum, designed for in-house counsel and executives, as well as private practice attorneys working for the OTC drug industry will provide invaluable insights on FDA’s most recent directives and compliance standards governing OTC drug production, marketing and distribution. Deb along with fellow panelists Kyle Y.

Compliance 52

Compliance Drugs Regulation FDA Approval 52

The Pharma Data

NOVEMBER 30, 2020

30, 2020 – Nearly 15% of talc-based cosmetic products analyzed in a recent study contained asbestos. Environmental Working Group (EWG) — an American advocacy nonprofit that commissioned the tests and did the analysis — said methods used by the cosmetics industry to screen talc supplies are inadequate. MONDAY, Nov.

Containment 52

Containment Production Cosmetics Contamination 52

XTalks

FEBRUARY 8, 2022

For the US Food and Drug Administration (FDA), the new year brings along a new set of food safety tasks to tackle. The list includes 30 food safety tasks that fall into several categories, including allergens, cosmetics, dietary supplements, food additives, Food Safety Modernization Act (FSMA), labeling and nutrition.

Cosmetics 97

Cosmetics Regulation Genome Genomics 97

FDA Law Blog

JUNE 2, 2022

Since 1984, generic drugs have been approved under ANDAs pursuant to section 505(j) of the Federal Food, Drug, and Cosmetic Act (FDCA); before 1984, no formal mechanism for an ANDA existed so FDA used sections 505(b) and 505(c) to approve follow-on drugs based on the Agency’s previous findings of safety and efficacy.

Drugs 52

Drugs Production Generic Drugs Cosmetics 52

Delveinsight

FEBRUARY 22, 2021

opaque, contain zinc oxide or titanium dioxide, and may be cosmetically unacceptable to some patients. The drug works by increasing skin pigmentation, which provides protection and improves sun tolerance. . Nevertheless, approval of scenesse gave the EPP market size growth a significant push. EPP patients with end?stage

Marketing 52

Marketing Research Cosmetics Gene 52

Camargo

JANUARY 27, 2021

Comparing Orphan Drug, Rare Pediatric Disease, and Humanitarian Use Device Designations. Orphan Drug Designation. 21 Code of Federal Regulations (CFR) §316 ; Orphan Drug Act. Section 529 of the Federal Food, Drug, and Cosmetic Act (FD&C Act)/ 21 United States Code (USC) §360ff. Drugs and biological products.

Production 138

Production Drugs Marketing Regulation 138

XTalks

MARCH 13, 2024

As the stars lined up on Hollywood Boulevard for the Oscars on Sunday evening, Eli Lilly took the stage with a TV ad that took shots at Hollywood’s latest weight loss frenzy — GLP-1 drugs. This isn’t the first time the GLP-1 drugs made it to the Oscars.

Medicine 52

Medicine Cosmetics FDA Approval Drugs 52

Fossil Remedies

OCTOBER 16, 2022

In a pharma business, you have a distribution network like a pharma manufacturing company, pharma marketing company, C&F agents, wholesalers/distributors/stockiest, retailers, and pharmacies. Every pharma company needs a drug license number to begin distribution, marketing, and manufacturing activities. Retail Drug License.

Licensing 52

Licensing Licensing Pharma Companies Cosmetics 52

FDA Law Blog

SEPTEMBER 6, 2023

Farquhar — A drug manufacturer’s bad post-inspection grade from the U.S. Food and Drug Administration – labeled an “Official Action Indicated” classification – is generally devastating for the facility, not least because it can stall FDA approval of applications to market drugs manufactured at the facility. By Douglas B.

Generic Drugs 45

Generic Drugs Manufacturing Drugs Cosmetics 45

The Pharma Data

MARCH 7, 2022

Food and Drug Administration announced it has made a low-risk determination for the marketing of products, including food, from two genome-edited beef cattle and their offspring after determining that the intentional genomic alteration (IGA) does not raise any safety concerns (low-risk determination). Today, the U.S.

Genome 52

Genome Genomics Production Marketing 52

Advarra

JULY 26, 2022

However, it’s not legal federally and is considered a Schedule I drug by the U.S. Drug Enforcement Administration (DEA), meaning it has no accepted medical use and a high potential for abuse. Even though CBD doesn’t meet criteria for IND exemption or the FDA’s OTC drug review, it still can be studied in humans.

Regulation 97

Regulation Research Production Cosmetics 97

FDA Law Blog

NOVEMBER 6, 2023

The LMG awards are reflective of HPM’s excellence across several of our core life sciences practices, from controlled substances work to drug development, to Hatch-Waxman, to drug pricing, to medical device regulation. is the largest dedicated food and drug law firm in the country. life sciences industry. 700 13th Street, N.W.,

Life Science 40

Life Science Cosmetics Regulation Drugs 40

FDA Law Blog

JANUARY 1, 2024

Perhaps FDA wanted us to remember 2023 as the year FDA succeeded in uncovering critical defects in drug and device manufacturing, and in critical trials. The FDA compliance data, sorted by category, shows there were 159 Warning Letters issued to drug manufacturers or sponsors during 2023, with 161 issued in calendar year 2022.

Manufacturing 59

Manufacturing Production Drugs FDA Compliance 59

pharmaphorum

FEBRUARY 11, 2022

Privately-held Mayoly Spindler is a specialist in gastroenterology and dermato-cosmetic products that has set itself the target of becoming a top 10 European OTC medicines company in the next 10 years. billion takeover of Clementia Pharma in 2019. billion takeover of Clementia Pharma in 2019. billion of its revenues last year.

Sales 100

Sales Pharma Companies Branding Cosmetics 100

XTalks

FEBRUARY 16, 2023

In 2022, Indorsia’s insomnia drug Quviviq (daridorexant) brought in a total of ₣6.5 Though the drug — which was launched in the US in May 2022 and in parts of Europe in November — wasn’t the focus of the disease-awareness campaign, Indorsia was using the campaign to establish its reputation in the sleep aid space. billion in 2022.

FDA Approval 105

FDA Approval Sales Branding Marketing 105

Camargo

SEPTEMBER 8, 2021

Some Drugs May Require Reclassification to Devices. On August 9, the FDA published a Federal Register notice requesting information and comments regarding products currently classified as drugs which may require reclassification as devices. This is in response to the decision from the U.S.

Development 186

Development Regulation Production Drugs 186

The Pharma Data

FEBRUARY 19, 2022

Food and Drug Administration is alerting the public that several categories of FDA-regulated products purchased from Jan. The agency is also advising that all drugs, medical devices, cosmetics and dietary supplements, regardless of packaging, be discarded. Today, the U.S. 1, 2021, through the present. 29 and Sep.

Contamination 52

Contamination Production Cosmetics Packaging 52

FDA Law Blog

MARCH 13, 2024

Part 2 (“Part Deux”) investigated the PTO’s position and recent decisions on PTE applications for patents covering products approved—and then withdrawn years later—under the Federal Food, Drug, and Cosmetic Act’s Accelerated Approval provisions (and otherwise). Lehman , No. 95-650-A (E.D. . 10,544,220 (the ‘220 patent). Exhibit 3.

Marketing 59

Marketing Production FDA Approval Generic Drugs 59

The Pharma Data

NOVEMBER 21, 2021

Food and Drug Administration approved Voxzogo (vosoritide) injection to improve growth in children five years of age and older with achondroplasia and open epiphyses (growth plates), meaning these children still have the potential to grow. director of the Division of General Endocrinology in the FDA’s Center for Drug Evaluation and Research.

FDA Approval 52

FDA Approval Drugs Regulation Genetics 52

Roots Analysis

FEBRUARY 20, 2022

Over the last decade, one of the major challenges faced by pharmaceutical players across the globe is low drug solubility. As a matter of fact, recently many drug developers have initiated formulating novel therapeutic interventions that utilize nanoparticles as a major component ( nanomedicines ). Nanoparticles Contract Manufacturing.

Contract Manufacturing 52

Contract Manufacturing Bioavailability Manufacturing Drug Delivery Systems 52

FDA Law Blog

NOVEMBER 16, 2021

Baumhardt provides counsel to medical device, in vitro diagnostic, and combination product manufacturers on a wide range of pre- and post-marketing regulatory topics. In the pre-market area, Ms. In the post-market area, Ms. In addition, Ms. Before joining HP&M, Ms.

Regulation 40

Regulation Compliance In-Vitro Cosmetics 40

XTalks

NOVEMBER 24, 2022

Earlier this week, the US Food and Drug Administration (FDA) sent out warning letters to five companies illegally selling CBD-infused food and beverage products. According to the warning letters, these products are considered adulterated under “section 402(a)(2)(C)(i) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act), 21 U.S.C.

Production 52

Production Branding Cosmetics Marketing 52

FDA Law Blog

AUGUST 21, 2023

FDA approves (or sometimes dictates depending on the product and regulatory pathway to market) the content of drug product labeling to set forth the conditions of use for which the benefits of the product outweigh the risks.

FDA Approval 40

FDA Approval Production Drugs Generic Drugs 40

FDA Law Blog

APRIL 21, 2024

Taiho’s counsel quickly followed up with a letter to FDA and a supplemental submission to the PTO in February 2024 arguing otherwise: “[P]ermission for commercial marketing” was not effective under the September 30, 2022 FDA letter because the product would have been misbranded if marketed thereunder. sections 331(a) and 352.(a)(l),

Production 59

Production FDA Approval Marketing Cosmetics 59

XTalks

JANUARY 19, 2021

The US Food and Drug Administration (FDA) has announced that in an operation with the US Customs and Border Protection (CBP) officers at the Dallas Fort Worth International Airport, 33,681 units of e-cigarettes were seized with a manufacturer’s suggested retail price of $719,453.

Production 98

Production Cosmetics Marketing Branding 98

pharmaphorum

JULY 27, 2021

Drug delivery specialist Aptar Group has agreed a deal to take a near two-thirds share in Voluntis, a French developer of digital therapeutics (DTx), with a view to taking full control of the company later this year. per share in the initial deal, which will give it a 64.6% stake in the company. stake in the company.

Drug Delivery 111

Drug Delivery Insulin Cosmetics Development 111

Fossil Remedies

APRIL 7, 2020

Having headquarters in Ahmadabad, Gujarat, ‘ Fossil Remedies ’ is the top most Pharma franchises company in India with long years of experience.They manufacture and market more than 2800+ Pharma products and indulge in 8 Special divisions. 150+ Skin & Cosmetic Products. They offer pharma franchise to interested parties. Rx Biotech.

Pharma Production 81

Pharma Production Pharma Companies Production Contract Manufacturing 81

FDA Law Blog

MAY 6, 2024

The draft guidance provides recommendations on what is required to meet cybersecurity obligations under section 524B of the Food, Drug and Cosmetic Act (FD&C). In addition, manufacturers need to submit plans for monitoring, identifying, and addressing post market cybersecurity vulnerabilities. are cybersecure.

Manufacturing 105

Manufacturing Cosmetics Regulation Containment 105

pharmaphorum

DECEMBER 15, 2022

Within the life sciences space, traditional ways of leveraging social media include marketing and spreading awareness of a disease or treatment. Healthcare Provider (HCP) marketing. Still, many pharma and medical marketers have been reluctant to engage with HCPs on social media. Direct-to-Consumer (DTC) marketing.

Clinical Trials 100

Clinical Trials Clinical Trials Life Science Marketing 100